Monashee Investment Management »

Celldex Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0M 100k 39.66
2020-06-30 $3.9M 300k 13.00

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Celldex Therapeutics

Wellington Management Company
Eventide Asset Management
Vanguard Group
Kynam Capital Management
Point72 Asset Management
Bellevue Group
Marshall Wace
Redmile Group
Octagon Capital Advisors
Commodore Capital
5AM Venture Management
Goldman Sachs Group
Sphera Funds Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Celldex Therapeutics